Form 4: Natera Executive Solomon Moshkevich Sells Shares to Cover Tax Obligations
SEC Form 4 Filing
Solomon Moshkevich, President of Clinical Diagnostics at Natera, Inc., sold 1,196 shares of common stock on April 29, 2024, to satisfy tax withholding obligations related to vesting RSUs.
Summary
- On April 29, 2024, Solomon Moshkevich, President of Clinical Diagnostics at Natera, Inc., sold 1,196 shares of Natera's common stock.
- The shares were sold at a price of $93.1387 per share.
- The sale was executed to cover tax withholding and remittance obligations associated with the vesting of Restricted Stock Units (RSUs).
- The transaction was conducted under a pre-arranged trading plan (Rule 10b5-1(c)) established on January 27, 2023.
- Following the transaction, Moshkevich directly owns 115,833 shares of Natera's common stock.
Sentiment
Score: 6
Explanation: The sentiment is neutral. The transaction is a routine sale of shares to cover tax obligations, which is a common practice and doesn't necessarily reflect a change in the executive's confidence in the company.
Industry Context
Sales of shares to cover tax obligations upon vesting of RSUs are a common practice among corporate executives and do not necessarily indicate a negative outlook on the company's future.
Key Dates
| Date | Description |
|---|---|
| January 27, 2023 | Date of Reporting Person's Stock Unit Agreement |
| April 29, 2024 | Date of transaction (stock sale) |
| May 01, 2024 | Date of signature for the Form 4 filing |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.